Dayton, MD, United States of America

Gabriela Grasa

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabriela Grasa. Retrieved from https://idiyas.com/inventor/gabriela-grasa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabriela Grasa: Innovator in Enantioselective Processes

Introduction

Gabriela Grasa is a prominent inventor based in Dayton, MD (US). She has made significant contributions to the field of chemistry, particularly in the development of processes for synthesizing complex compounds. Her work is characterized by a focus on enantioselectivity, which is crucial in the production of pharmaceuticals.

Latest Patents

Gabriela holds one patent titled "Enantioselective process for preparing a substituted alkanoic acid." This invention is directed towards a process for enantioselectively preparing substituted piperidine alkanoic acid integrin antagonist compounds. This innovative approach has the potential to enhance the efficacy of various therapeutic agents.

Career Highlights

Gabriela is currently employed at Janssen Pharmaceutica NV, a company known for its commitment to developing innovative medicines. Her role involves extensive research and development, where she applies her expertise in chemistry to create new solutions for healthcare challenges.

Collaborations

Throughout her career, Gabriela has collaborated with notable colleagues, including William Alvin Kinney and Christopher A. Teleha. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Gabriela Grasa's contributions to the field of enantioselective processes exemplify her dedication to innovation in pharmaceutical chemistry. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes through the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…